SAREPTA THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
SAREPTA THERAPEUTICS, INC. (SRPT) reported Diluted Shares Outstanding (Weighted Average) of 105.43 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 105.43M shares, a 1.12% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 121.92M shares, a 25.22% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 104.84M shares, a 21.04% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 100.24M shares, a 0.21% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 100.12M shares, a 7.19% decline from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 107.88M shares, a 16.75% increase from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 92.40M shares, a 5.53% increase from fiscal 2022.
- SAREPTA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 87.56M shares, a 7.75% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 105.43M shares 10-Q · filed 2026-08-05 | 122.26M shares 10-Q · filed 2026-08-05 | 110.73M shares derived: average of 3 quarters · filed 2026-08-05 | 108.11M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | 121.92M shares 10-Q · filed 2026-05-06 | 113.38M shares derived: average of 2 quarters · filed 2026-05-06 | 109.00M shares derived: average of 3 quarters · filed 2026-05-06 | 108.41M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | 104.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 102.54M shares derived: average of 2 quarters · filed 2026-03-02 | 103.90M shares derived: average of 3 quarters · filed 2026-08-05 | 100.12M shares 10-K · filed 2026-03-02 | |||
| 2025-09-30 | 100.24M shares 10-Q · filed 2025-11-06 | 103.43M shares derived: average of 2 quarters · filed 2026-08-05 | 98.55M shares 10-Q · filed 2025-11-06 | 109.25M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | 106.62M shares 10-Q · filed 2026-08-05 | 97.69M shares 10-Q · filed 2026-08-05 | 112.26M shares derived: average of 3 quarters · filed 2026-08-05 | 109.30M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | 97.36M shares 10-Q · filed 2026-05-06 | 115.07M shares derived: average of 2 quarters · filed 2026-05-06 | 110.20M shares derived: average of 3 quarters · filed 2026-05-06 | 107.43M shares derived: average of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | 132.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 116.62M shares derived: average of 2 quarters · filed 2026-03-02 | 110.79M shares derived: average of 3 quarters · filed 2026-03-02 | 107.88M shares 10-K · filed 2026-03-02 | |||
| 2024-09-30 | 100.45M shares 10-Q · filed 2025-11-06 | 99.80M shares derived: average of 2 quarters · filed 2025-11-06 | 99.57M shares 10-Q · filed 2025-11-06 | 100.62M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | 99.14M shares 10-Q · filed 2025-08-06 | 99.13M shares 10-Q · filed 2025-08-06 | 100.67M shares derived: average of 3 quarters · filed 2026-03-02 | 97.73M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | 99.11M shares 10-Q · filed 2025-05-06 | 101.44M shares derived: average of 2 quarters · filed 2026-03-02 | 97.26M shares derived: average of 3 quarters · filed 2026-03-02 | 95.13M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | 103.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 96.33M shares derived: average of 2 quarters · filed 2026-03-02 | 93.80M shares derived: average of 3 quarters · filed 2026-03-02 | 92.40M shares 10-K · filed 2026-03-02 | |||
| 2023-09-30 | 88.89M shares 10-Q · filed 2024-11-06 | 88.82M shares derived: average of 2 quarters · filed 2024-11-06 | 88.61M shares 10-Q · filed 2024-11-06 | 88.41M shares derived: average of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | 88.74M shares 10-Q · filed 2024-08-07 | 88.47M shares 10-Q · filed 2024-08-07 | 88.26M shares derived: average of 3 quarters · filed 2025-02-28 | 88.10M shares derived: average of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | 88.19M shares 10-Q · filed 2024-05-01 | 88.01M shares derived: average of 2 quarters · filed 2025-02-28 | 87.89M shares derived: average of 3 quarters · filed 2025-02-28 | 87.79M shares derived: average of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | 87.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 87.73M shares derived: average of 2 quarters · filed 2025-02-28 | 87.66M shares derived: average of 3 quarters · filed 2025-02-28 | 87.56M shares 10-K · filed 2025-02-28 | |||
| 2022-09-30 | 87.63M shares 10-Q · filed 2023-11-01 | 87.63K shares 10-Q · filed 2022-11-02 | 87.57M shares derived: average of 2 quarters · filed 2023-11-01 | 87.47M shares 10-Q · filed 2023-11-01 | 87.47K shares 10-Q · filed 2022-11-02 | 146.80M shares derived: average of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | 87.51M shares 10-Q · filed 2023-08-02 | 87.51K shares 10-Q · filed 2022-08-02 | 87.38M shares 10-Q · filed 2023-08-02 | 87.38K shares 10-Q · filed 2022-08-02 | 166.52M shares derived: average of 3 quarters · filed 2024-02-28 | 124.91M shares derived: average of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | 87.25M shares 10-Q · filed 2023-05-02 | 87.25K shares 10-Q · filed 2022-05-04 | 206.03M shares derived: average of 2 quarters · filed 2024-02-28 | 137.38M shares derived: average of 3 quarters · filed 2024-02-28 | 103.06M shares derived: average of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | 324.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 162.44M shares derived: average of 2 quarters · filed 2024-02-28 | 108.32M shares derived: average of 3 quarters · filed 2024-02-28 | 81.26M shares 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 79.88K shares 10-Q · filed 2022-11-02 | 79.81K shares derived: average of 2 quarters · filed 2022-11-02 | 79.69K shares 10-Q · filed 2022-11-02 | 77.96M shares derived: average of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | 79.75K shares 10-Q · filed 2022-08-02 | 79.75M shares 10-Q · filed 2021-08-04 | 79.60K shares 10-Q · filed 2022-08-02 | 79.60M shares 10-Q · filed 2021-08-04 | 103.92M shares derived: average of 3 quarters · filed 2023-02-28 | 77.96M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | 79.45K shares 10-Q · filed 2022-05-04 | 79.45M shares 10-Q · filed 2021-05-05 | 155.84M shares derived: average of 2 quarters · filed 2023-02-28 | 103.92M shares derived: average of 3 quarters · filed 2023-02-28 | 97.43M shares derived: average of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | 311.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 155.83M shares derived: average of 2 quarters · filed 2023-02-28 | 129.88M shares derived: average of 3 quarters · filed 2023-02-28 | 77.96M shares 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 78.50K shares 10-Q · filed 2021-11-03 | 78.50M shares 10-Q · filed 2020-11-05 | 39.02M shares derived: average of 2 quarters · filed 2021-11-03 | 77.64K shares 10-Q · filed 2021-11-03 | 77.64M shares 10-Q · filed 2020-11-05 | 57.26M shares derived: average of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | 77.97M shares 10-Q · filed 2021-08-04 | 77.20M shares 10-Q · filed 2021-08-04 | 76.32M shares derived: average of 3 quarters · filed 2022-03-01 | 75.79M shares derived: average of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | 76.43M shares 10-Q · filed 2021-05-05 | 75.50M shares derived: average of 2 quarters · filed 2022-03-01 | 75.06M shares derived: average of 3 quarters · filed 2022-03-01 | 74.78M shares derived: average of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | 74.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 74.37M shares derived: average of 2 quarters · filed 2022-03-01 | 74.23M shares derived: average of 3 quarters · filed 2022-03-01 | 73.61M shares 10-K · filed 2022-03-01 | |||
| 2019-09-30 | 74.18M shares 10-Q · filed 2020-11-05 | 74.07M shares derived: average of 2 quarters · filed 2020-11-05 | 73.30M shares 10-Q · filed 2020-11-05 | 72.13M shares derived: average of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | 73.96M shares 10-Q · filed 2020-08-05 | 72.85M shares 10-Q · filed 2020-08-05 | 71.44M shares derived: average of 3 quarters · filed 2021-03-01 | 70.13M shares derived: average of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | 71.73M shares 10-Q · filed 2020-05-06 | 70.18M shares derived: average of 2 quarters · filed 2021-03-01 | 68.86M shares derived: average of 3 quarters · filed 2021-03-01 | 68.02M shares derived: average of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | 68.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 67.42M shares derived: average of 2 quarters · filed 2021-03-01 | 66.78M shares derived: average of 3 quarters · filed 2021-03-01 | 66.25M shares 10-K · filed 2021-03-01 | |||
| 2018-09-30 | 66.21M shares 10-Q · filed 2019-11-07 | 65.85M shares derived: average of 2 quarters · filed 2019-11-07 | 65.45M shares 10-Q · filed 2019-11-07 | 65.15M shares derived: average of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | 65.48M shares 10-Q · filed 2019-08-07 | 65.06M shares 10-Q · filed 2019-08-07 | 64.80M shares derived: average of 3 quarters · filed 2019-08-07 | 63.91M shares derived: average of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | 64.63M shares 10-Q · filed 2018-05-03 | 64.45M shares derived: average of 2 quarters · filed 2019-02-28 | 63.39M shares derived: average of 3 quarters · filed 2019-02-28 | 61.29M shares derived: average of 4 quarters · filed 2019-02-28 | |||
| 2017-12-31 | 64.28M shares 10-K · filed 2019-02-28 | 62.77M shares derived: average of 2 quarters · filed 2019-02-28 | 60.17M shares derived: average of 3 quarters · filed 2019-02-28 | 58.82M shares 10-K · filed 2020-02-26 | |||
| 2017-09-30 | 61.26M shares 10-K · filed 2019-02-28 | 58.12M shares derived: average of 2 quarters · filed 2019-02-28 | 57.42M shares derived: average of 3 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | 54.98M shares 10-K · filed 2019-02-28 | 56.18M shares 10-Q · filed 2018-08-08 | |||||
| 2017-03-31 | 56.01M shares 10-K · filed 2019-02-28 | ||||||
| 2016-06-30 | 46.16M shares 10-Q · filed 2017-08-03 | 45.93M shares 10-Q · filed 2017-08-03 | |||||
| 2016-03-31 | 45.70M shares 10-Q · filed 2017-05-04 | ||||||
| 2012-12-31 | 26.31M shares 10-K · filed 2014-03-03 | 24.57M shares derived: average of 2 quarters · filed 2014-03-03 | 23.93M shares derived: average of 3 quarters · filed 2014-03-03 | 23.60M shares derived: average of 4 quarters · filed 2014-03-03 | |||
| 2012-09-30 | 22.82M shares 10-K · filed 2014-03-03 | 22.74M shares derived: average of 2 quarters · filed 2014-03-03 | 22.69M shares 10-Q · filed 2012-11-07 | 22.68M shares derived: average of 4 quarters · filed 2014-03-03 | |||
| 2012-06-30 | 22.66M shares 10-K · filed 2014-03-03 | 22.62M shares 10-Q · filed 2012-08-07 | 22.64M shares derived: average of 3 quarters · filed 2014-03-03 | 22.63M shares derived: average of 4 quarters · filed 2014-03-03 | |||
| 2012-03-31 | 22.62M shares 10-K · filed 2014-03-03 | 135.74M shares 10-Q · filed 2012-05-10 | 22.62M shares derived: average of 2 quarters · filed 2014-03-03 | 22.62M shares derived: average of 3 quarters · filed 2014-03-03 | 22.76M shares derived: average of 4 quarters · filed 2014-03-03 | ||
| 2011-12-31 | 22.62M shares 10-K · filed 2013-03-15 | 22.62M shares derived: average of 2 quarters · filed 2013-03-15 | 22.80M shares derived: average of 3 quarters · filed 2013-03-15 | 129.59M shares 10-K · filed 2012-03-13 | |||
| 2011-09-30 | 22.62M shares 10-K · filed 2013-03-15 | 22.89M shares derived: average of 2 quarters · filed 2013-03-15 | 21.25M shares 10-Q · filed 2012-11-07 | ||||
| 2011-06-30 | 23.15M shares 10-K · filed 2013-03-15 | 138.92M shares 10-Q · filed 2011-08-08 | 21.67M shares 10-Q · filed 2012-08-07 | 130.02M shares 10-Q · filed 2011-08-08 | |||
| 2011-03-31 | 20.21M shares 10-K · filed 2013-03-15 | 121.28M shares 10-Q · filed 2012-05-10 | |||||
| 2010-12-31 | 111.23M shares 10-K · filed 2012-03-13 | ||||||
| 2010-06-30 | 110.38M shares 10-Q · filed 2011-08-08 | 110.40M shares 10-Q · filed 2011-08-08 | |||||
| 2009-12-31 | 93.09M shares 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |